Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rudnick

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|July 20, 1990
Growth and erosion of thin solid filmsG S Bales, R Bruinsma, E A Eklund, et al.
VASA. Supplementum|January 1, 1989
Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunctionH Porst, H van Ahlen, T Block, et al.
Immunopharmacology and Immunotoxicology|January 1, 1987
Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferonG W Stevenson, S Hall, S J Rudnick, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|July 20, 1990
Growth and erosion of thin solid filmsG S Bales, R Bruinsma, E A Eklund, et al.
VASA. Supplementum|January 1, 1989
Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunctionH Porst, H van Ahlen, T Block, et al.
Immunopharmacology and Immunotoxicology|January 1, 1987
Halothane anesthesia decreases human monocyte hydrogen peroxide generation. Protection of monocytes by activation with gamma interferonG W Stevenson, S Hall, S J Rudnick, et al.
Journal of Neuro-Oncology|October 19, 2015
A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patientsJ J Raizer, P Giglio, J Hu, et al.
Pageof 4